Benchmark Holdings PLC (LSE:BMK) - Share price - Overview

Stock Report

Benchmark Holdings PLC BMK

Last Price
GBX74.00

Day Change
0.00|0.00%

As of 23/06/2017
16:00:32 BST | GBX
Minimum 15 Minutes Delay.

Last Close74.00p
Day Range74.15 - 74.20
Mkt Cap386.50Mil
52-Wk Range48.00 - 111.50
Yield %0.00
ISINGB00BGHPT808
Volume19,062
P/E-80.00
P/S2.83
P/CF-24.24

Share Price

Total Returns 23/06/2017

 Chg (%)  
More ...
Benchmark Holdings PLC-19.13 
FTSE 100 TR GBP-0.50
 
Financials
201420152016
More ...
Income Statement
Turnover35.3544.20109.38
Operating Profit-1.19-11.60-20.47
Net Profit-1.32-11.76-18.35
Reported EPS-1.04-5.96-4.39
Balance Sheet
Current Assets32.5839.22102.49
Non Current Assets15.9394.85408.42
Total Assets48.50134.07510.91
Current Liabilities9.5226.3233.71
Total Liabilities11.2541.97143.21
Total Equity37.2592.10367.70
Cash Flow
Operating Cash Flow0.28-8.85-9.10
Net Change in Cash14.77-2.9524.58
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-2.321.04-70.88---
20180.201.7668.2042.140.62--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
26/04/2017PurchaseThe Hon Alex Hambro90.0053,12547,813.00
13/03/2017Exercise of OptionMr. Mark Plampin0.1056,93857.00
15/02/2017PurchaseKevin Quinn94.0425,00023,510.00
01/12/2016Exercise of OptionMr. Mark Plampin10.00135,00013,500.00

Company Profile

Benchmark Holdings PLC is engaged in the development, manufacture and commercialisation of animal health vaccines, medicines, biocides and diagnostics with a focus on aquaculture.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

524 of 1843 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(24/01/2017) ch - "...we look forward to the future with great confidence"

Next Event 27/06/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)47.3515.5116.74
Div Yld (E)0.003.544.17
PEG (E)0.230.460.95
ROCE-5.78190.29209.95
Op Mrgn-6.62-3.24-100.19
EPS Grwth206.4145.3233.33
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanThe Hon Alex Hambro
Chief Executive OfficerMr. Malcolm Pye
Chief Financial OfficerMr. Mark Plampin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.